The 20 Best Thymic Epithelial Tumor Doctors Near Me in Ann Arbor, MI

Dr. Kalemkerian completed his medical education and training at Northwestern University and Johns Hopkins Oncology Center. From 1993-1999, he was a physician-scientist at Wayne State University/Karmanos Cancer Institute in Detroit. Since 1999, he has been on faculty in the Division of Hematology/Oncology at the University of Michigan, where he currently serves as the Associate Division Chief for Faculty Development and Education and the Associate Director of the Hem/Onc Fellowship Program. In addition to his work at UM, Dr. Kalemkerian has served on and led numerous grant review sections, editorial boards, and committees of national and international professional societies. He is a former chair of the NCCN Small Cell Lung Cancer Guideline Panel and the ASCO Scientific Program Committee’s Metastatic NSCLC and Professional Development and Education Tracks. Dr. Kalemkerian’s clinical interest is the care of people with lung cancer, thymic tumors, and mesothelioma, and his academic research interest is clinical and translational trials for thoracic cancers. His honors include the receipt of the American Society of Clinical Oncology’s (ASCO) Excellence in Teaching Award, the University of Michigan Outstanding Clinician Award, and Fellow of ASCO recognition. He has given over 230 invited lectures, authored more than 200 research articles, reviews, commentaries and book chapters, and edited two books on lung cancer. Dr. Kalemkerian is rated as an Advanced provider by MediFind in the treatment of Thymic Epithelial Tumor. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma. Dr. Kalemkerian is board certified in Internal Medicine and Medical Oncology.

Bryan J. Schneider, MD is a Professor of Internal Medicine in the Division of Hematology/ Oncology at the University of Michigan, Ann Arbor, Michigan, and is the Section Head for the medical thoracic oncology team who treats lung cancer, esophageal cancer, mesothelioma, thymoma and carcinoid tumors.Dr. Schneider earned his medical degree from Indiana University in 1998. He also completed an internship and residency in internal medicine at the Indiana University School of Medicine and served as Chief Resident in 2001. He completed a fellowship in hematology/oncology at the University of Michigan. He joined the faculty at the University of Michigan as an Assistant Professor in 2005 and was an Assistant Professor at Cornell University in New York City from 2008 to 2014. He returned to the University of Michigan in 2015.Dr. Schneider is a member of the American Society of Clinical Oncology and the International Association for the Study of Lung Cancer. He has served as a member of the Experimental Therapeutics Study Section of the National Institutes of Health and serves on numerous other scientific medical committees. These include the ASCO thoracic guideline advisory group, and the steering committee for the National Cancer Center Network (NCCN) guidelines.Dr. Schneider has published extensively in peer-reviewed journals and has written several book chapters on the subject of lung cancer. He is married with twin boys and a cat. Dr. Schneider is rated as an Advanced provider by MediFind in the treatment of Thymic Epithelial Tumor. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Tissue Biopsy. Dr. Schneider is board certified in Medical Oncology.

Rishindra M. Reddy, M.D., is the José José Alvarez Research Professor in Thoracic Surgery. He was born and raised in Michigan. He earned his undergraduate and medical degrees at Northwestern University, and completed his general surgery residency at Washington University-Barnes Jewish Hospital in St. Louis, Missouri. His spent two years during his residency, as a Clinical Research Fellow at the National Cancer Institute in Bethesda, Maryland. He completed his Thoracic Surgery residency at the University of Washington and was a visiting fellow at Memorial Sloan Kettering Cancer Center in New York. His academic interests include improving outcomes for patients with thoracic cancers, molecular targeting for thoracic cancers, resident and medical student education.Clinical Specialization: Dr. Reddy's clinical interests include all aspects of general thoracic surgery including thoracic oncology, minimally invasive techniques and robotics surgery, esophageal diseases, pectus repairs and therapy for end stage lung disease including transplantation and lung volume surgery. Dr. Reddy is rated as an Advanced provider by MediFind in the treatment of Thymic Epithelial Tumor. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Hiatal Hernia, Esophageal Cancer, Endoscopy, and Lung Transplant. Dr. Reddy is board certified in Surgery and Thoracic & Cardiac Surgery.

David Odell is a General Surgeon and a Thoracic Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Odell is rated as an Advanced provider by MediFind in the treatment of Thymic Epithelial Tumor. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Lung Nodules, Non-Small Cell Lung Cancer (NSCLC), Endoscopy, and Gastrostomy.

Shruti Jolly MD is an Associate Professor and Associate Chair of Community Practices in the Department of Radiation Oncology at the University of Michigan. She received her undergraduate and medical degrees at Wayne State University as a Presidential Scholar. In 2007, she completed her medical training at William Beaumont Hospital in Royal Oak, Michigan where she served as chief resident and received the RSNA Roentgen Resident Research Award. Dr. Jolly then joined the faculty at the University of Michigan Department of Radiation Oncology. Dr. Jolly directs the treatment of thoracic, gynecologic and endocrine malignancies. She also serves as the director of Brachytherapy, specializing in High Dose Rate (HDR) brachytherapy procedures. Additionally, she is the principal investigator of numerous clinical protocols designed to individualize the radiation therapy of lung and gynecologic cancer patients. Dr. Jolly has authored numerous publications in peer-reviewed journals. As Associate chair of Community Practices, she oversees the standardization and quality of care of patients receiving radiation therapy at the numerous UM Radiation Oncology community practices across the state of Michigan. In addition she also serves as a consultant for the Michigan Radiation Oncology Quality Consortium (MROQC) focused on quality improvement in patients undergoing radiation therapy for breast cancer, lung cancer and bone metastases. Dr. Jolly is rated as an Advanced provider by MediFind in the treatment of Thymic Epithelial Tumor. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Adrenal Cancer, and Pleuropulmonary Blastoma. Dr. Jolly is board certified in Radiation Oncology.

Dr. Lagisetty serves as an Assistant Professor of Surgery in the Section of Thoracic Surgery at the University of Michigan Health System.He is a graduate from the University of Alabama at Birmingham with a degree in Philosophy in 2003 and medical degree in 2007. His General Surgical residency was completed at Beth Israel Deaconess Medical Center/Harvard Medical School. Dr. Lagisetty spent two years as a Clinical Research Fellow at the National Institutes of Health studying tumor immunology and genetic engineering/therapy. After residency he completed a two year Thoracic Surgery Fellowship at the University of Michigan.Clinical Specialization: Dr. Lagisetty specializes in all areas of general thoracic surgery, benign and malignant esophageal disorders, benign and malignant lung resections, minimally invasive including robotic techniques, lung transplantation. Dr. Lagisetty is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Hiatal Hernia, Congenital Diaphragmatic Hernia, Hernia, Endoscopy, and Lung Transplant. Dr. Lagisetty is board certified in Surgery and Thoracic & Cardiac Surgery.

Andrew C. Chang, M.D., is the Cameron Haight Collegiate Professor of Thoracic Surgery at the University of Michigan. After completing his undergraduate education at the Massachusetts Institute of Technology and medical education at The Johns Hopkins University he pursued general surgical residency at Vanderbilt University. During this time he also obtained an individual National Research Service Award from the National Institutes of Health to study cardiothoracic transplantation with Richard N. Pierson, III, M.D. He then continued as a thoracic surgical resident and subsequently thoracic surgical fellow at the University of Michigan, completing these in 2003, before joining the faculty. Dr. Chang is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Achalasia, Hiatal Hernia, Hernia, Endoscopy, and Lung Transplant. Dr. Chang is board certified in Surgery and Thoracic & Cardiac Surgery.

Dr. Hearn is an Associate Professor in the Department of Radiation Oncology at the University of Michigan. He completed his medical training at Harvard Medical School and his residency in radiation oncology at Cleveland Clinic. Dr. Hearn investigates mechanisms by which prostate cancer may become resistant to current treatments.Dr. Hearn also treats bladder cancer and has been impressed by the promising responses (sometimes dramatic and long-lasting) that some patients with bladder cancer have when treated with immunotherapy to harness the body’s immune system. He is interested in the intersection of immunotherapy and radiation therapy.Additionally, Dr. Hearn is interested in novel techniques to improve the safety and efficacy of radiation therapy for lung cancer by modulating cytokines relevant to lung injury. Dr. Hearn is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, Muscle Invasive Bladder Cancer, and Prostatectomy. Dr. Hearn is board certified in Radiation Oncology.

Dr. Daniel Chang is a nationally and internationally recognized expert in radiotherapy for GI malignancies. His primary research interest is in advanced radiotherapy techniques, primarily with stereotactic body radiotherapy (SBRT). He has led several studies investigating and establishing the efficacy and safety for SBRT for these diseases for liver and pancreatic tumors. His other research interests include normal tissue tolerances, quality of life after radiotherapy, and combining radiotherapy with targeted agents. In addition, he has a strong interest in the use of radiotherapy, particularly in combination with systemic agents, in patients with metastatic disease. Another area of interest is in health care utilization for patients with metastatic disease and using machine learning and other approaches to optimize care during the end-of-life period.Dr. Chang is interested in developing novel modalities and technologies for delivering radiotherapy. He previously led the FDA trial that led to approval of PET-guided radiotherapy, which in broader terms, is called Biology-guided radiotherapy. In addition, he has experience with MR-guided radiotherapy, and he is interested in exploring the role of particle therapy and heave ion radiotherapy.Dr. Chang received his MD from Wayne State University in 2002 and completed his residency in Radiation Oncology at the University of Florida in Gainesville, Florida in 2007. He then joined the Department of Radiation Oncology at Stanford University from 2007-2022, having previously served as residency program director from 2012-2017 and the Vice Chair of Clinical Operations from 2017-2022 where he was also the Sue and Bob McCollum Professor in Radiation Oncology.Dr. Chang is a member of the American Society of Radiation Oncology (ASTRO), American Radium Society (ARS), and the American Society of Clinical Oncology (ASCO). He serves on the scientific committee for ASTRO, ASCO, and GI ASCO. He has authored or co-authored over 190 peer-reviewed publications for journals including Journal of Clinical Oncology, Journal of the National Cancer Institute, Clinical Cancer Research, Radiology, International Journal of Radiation Oncology, Biology, and Physics, Radiotherapy and Oncology, and Cancer. He served as the senior editor for the GI section of the International Journal of Radiation Oncology, Biology, and Physics from 2013-2017 and is currently on the editorial board for Practical Radiation Oncologysince 2020. He served on the Hepatobiliary Panel for the National Cancer Comprehensive Network (NCCN) guidelines from 2013-2022, helping to shape national guidelines for the work-up, diagnosis, and treatment of patients with hepatobiliary cancers. He is currently the track chair for the GI track for the ASTRO Annual Meeting Scientific Committee. He also serves on the Education Committee for the Gastrointestinal Cancer - Gastroesophageal, Pancreatic, and Hepatobiliary Track for the ASCO annual meeting starting in 2023. Dr. Chang is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), and Familial Pancreatic Cancer. Dr. Chang is board certified in Radiation Oncology.

James Fugazzi is a Radiation Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Fugazzi is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), and Familial Prostate Cancer. Dr. Fugazzi is board certified in Radiation Oncology.

Elliot Wakeam is a Thoracic Surgeon and a General Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Wakeam is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Esophageal Cancer, Lung Transplant, and Endoscopy.

Dr. Jackson is an Assistant Professor in the Department of Radiation Oncology at the University of Michigan. He performed his residency in radiation oncology at the University of Michigan, and subsequently joined the faculty upon completion of his training. Within the Department of Radiation Oncology, he serves as the co-Chief of the Genitourinary Radiotherapy Program. Within the Rogel Cancer he is the co-Director of the multidisciplinary Spine Oncology Program.Dr. Jackson’s research focuses mainly on improving outcomes for men with aggressive or recurrent prostate cancer, and he has published extensively on this topic. Dr. Jackson is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Upper Tract Urothelial Carcinoma (UTUC), and Penile Cancer. Dr. Jackson is board certified in Radiation Oncology.

Ronald Maggiore is a Geriatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Maggiore is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), EGFR Positive Lung Cancer, and Squamous Cell Lung Carcinoma.

Eva Bieniek is a Radiation Oncologist practicing medicine in Ypsilanti, Michigan. Dr. Bieniek is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Posterior Fossa Tumor, Lung Cancer, Pleuropulmonary Blastoma, and Endometrial Cancer.

Richard Cattaneo is a Radiation Oncologist practicing medicine in Ypsilanti, Michigan. Dr. Cattaneo is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Posterior Fossa Tumor, and Primitive Neuroectodermal Tumor (PNET).

Tareq Baghdadi is a Hematologist practicing medicine in Ypsilanti, Michigan. Dr. Baghdadi is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. He is also highly rated in 40 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Colorectal Cancer, Pleuropulmonary Blastoma, Tissue Biopsy, and Bone Marrow Aspiration.

Kumari Adams is a Thoracic Surgeon practicing medicine in Ypsilanti, Michigan. Dr. Adams is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Hiatal Hernia, Lung Nodules, Pleuropulmonary Blastoma, Gastrostomy, and Endoscopy.

Melanie Edwards is a Thoracic Surgeon practicing medicine in Ypsilanti, Michigan. Dr. Edwards is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Lung Nodules, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, Gastrostomy, and Endoscopy.

Niklas Mackler is a Hematologist practicing medicine in Ypsilanti, Michigan. Dr. Mackler is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Pleuropulmonary Blastoma, Familial Colorectal Cancer, and Lung Cancer.

Erik Carson is a Hematologist practicing medicine in Ypsilanti, Michigan. Dr. Carson is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Breast Cancer, and Paget Disease of the Breast.